Delivery Order SPE2DB24D1107-SPE2DB25FZGP4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,543.64 firm fixed-price delivery order for M-M-R II vaccine vials, with a completion date of September 2, 2025. This competitively awarded contract, with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,039.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,772.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,096.44 to AmerisourceBergen Drug Corp on July 29, 2025, for M-M-R II vaccine vials. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,720.60 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.10 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with performance in Conshohocken, Pennsylvania and completion targeted for August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,573.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to supply the...
- The Defense Logistics Agency awarded a $1,479.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 25, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $34,811.78 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGP4Delivery Order
The Defense Logistics Agency awarded a $11,852.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 12, 2025. This non-competitive, competitively awarded delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio primarily with the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX indefinite delivery contract enables flexible procurement of a broad range of pharmaceutical products and medical supplies—including vaccines, specialty medications, generic and brand-name drugs, and medical devices—to support military healthcare systems worldwide. This delivery order for measles, mumps, and rubella vaccine vials reflects the contractor's critical role in supplying medical commodities to the Defense Health Agency and other federal healthcare customers across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/11/25 |